[{"Assets_0_Q3_USD":97523000.0,"CommonStockSharesOutstanding_0_Q3_shares":19141645.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-22667000.0,"NetIncomeLoss_1_Q3_USD":-9148000.0,"NetIncomeLoss_3_Q3_USD":-25508000.0,"StockholdersEquity_0_Q3_USD":86497000.0,"Ticker":"KZR","CIK":"1645666","name":"KEZAR LIFE SCIENCES, INC.","OfficialName":"Kezar Life Sciences Inc. Common Stock","form":"10-Q","period":"20190930","fy":"2019.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"829139908.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20191107"}]